We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

106 hedge funds and large institutions have $1.49B invested in Stoke Therapeutics in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 13

28% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 25

14% more funds holding

Funds holding: 93 → 106 (+13)

2.63% less ownership

Funds ownership: 107.44% → 104.81% (-2.6%)

33% less call options, than puts

Call options by funds: $3M | Put options by funds: $4.46M

38% less capital invested

Capital invested by funds: $2.39B → $1.49B (-$902M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
106
Holders Change
+13
Holders Change %
+13.98%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
26
Increased
32
Reduced
25
Closed
13
Calls
$3M
Puts
$4.46M
Net Calls
-$1.47M
Net Calls Change
-$5.74M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$17.8M
2
Morgan Stanley
Morgan Stanley
New York
+$11.7M
3
SFM
Sphera Funds Management
Israel
+$8.58M
4
Two Sigma Investments
Two Sigma Investments
New York
+$5.83M
5
RI
RTW Investments
New York
+$5.69M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$41.2M
2
GGHC
Gilder Gagnon Howe & Co
New York
-$11.7M
3
RG
Redmile Group
California
-$8.09M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$7.82M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$2.03M +$2.97M +52,200 New
N
27
Nuveen
North Carolina
$2M +$27.3K +480 +0.9%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.99M -$174K -3,055 -6%
ACP
29
Acuta Capital Partners
California
$1.75M -$2.7M -47,500 -51%
Citigroup
30
Citigroup
New York
$1.71M +$2.28M +40,015 +1,020%
TD Asset Management
31
TD Asset Management
Ontario, Canada
$1.44M +$323K +5,673 +18%
Rafferty Asset Management
32
Rafferty Asset Management
New York
$1.35M +$1.98M +34,820 New
Citadel Advisors
33
Citadel Advisors
Florida
$1.26M +$1.84M +32,330 New
Aviva
34
Aviva
United Kingdom
$1.18M -$369K -6,487 -18%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$1.15M +$1.3M +22,782 +331%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$971K – – –
Two Sigma Advisers
37
Two Sigma Advisers
New York
$955K +$1.4M +24,600 New
Swiss National Bank
38
Swiss National Bank
Switzerland
$800K +$102K +1,800 +10%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$795K +$96.7K +1,699 +9%
AllianceBernstein
40
AllianceBernstein
Tennessee
$703K +$39.9K +700 +4%
Barclays
41
Barclays
United Kingdom
$686K +$712K +12,514 +244%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$672K – – –
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$602K -$9.39K -165 -1%
UBS Group
44
UBS Group
Switzerland
$595K +$872K +15,315 New
BC
45
Birchview Capital
Vermont
$583K -$285K -5,000 -25%
SG Americas Securities
46
SG Americas Securities
New York
$562K +$824K +14,468 New
B
47
Bailard
California
$548K – – –
HS
48
HighVista Strategies
Massachusetts
$532K -$226K -3,976 -23%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$513K +$120K +2,100 +19%
Bank of America
50
Bank of America
North Carolina
$497K +$528K +9,282 +263%
1
2
3 4 5

STOK Hedge Fund Activity: Q1 2021 in Review

106 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q1 2021, worth a combined $1.49B — down 38% from $2.39B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new STOK positions and 13 closed out — a net gain of 13 holders — while 32 added to existing stakes and 25 trimmed.

The largest buyer was State Street, adding an estimated $17.8M. The largest seller was Fidelity Investments, cutting an estimated $41.2M.

  • 106 institutional investors held Stoke Therapeutics (STOK) as of Q1 2021, up from 93 in Q4 2020.
  • Funds reported $1.49B of Stoke Therapeutics stock for Q1 2021, down 38% quarter-over-quarter.
  • 26 funds opened new Stoke Therapeutics positions in Q1 2021 and 13 closed out, a net change of +13 holders.
  • The largest Stoke Therapeutics buyer in Q1 2021 was State Street, an estimated $17.8M added.
  • The largest Stoke Therapeutics seller in Q1 2021 was Fidelity Investments, an estimated $41.2M sold.

Based on aggregated 13F filings for Q1 2021.